In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Arrowstreet Capital Limited Partnership bought a new stake in shares of Haleon plc (NYSE:HLN – Free Report) during the fourth ...

April 15 (Reuters) - British consumer healthcare group Haleon (HLN.L), opens new tab on Tuesday said it gained full control of its Chinese joint venture after acquiring Tianjin Pharmaceutical Da ...

Haleon PLC closed 10.34% below its 52-week high of £4.18, which the company achieved on March 4th.

In a report released today, Cedric Besnard from Citi maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon ...

In trading on Monday, shares of Haleon plc (Symbol: HLN) crossed below their 200 day moving average of $9.72, changing hands as low as $9.19 per share. Haleon plc shares are currently trading down ...

Haleon PLC closed 11.52% short of its 52-week high of £4.18, which the company reached on March 4th.

Haleon plc (LSE/NYSE:HLN), a global leader in consumer health with a market capitalization of $43 billion, reported on Monday that... ByInvesting.com • Apr 11, 2025 Haleon receives A3 rating ...

In a report released today, Iain Simpson from Barclays maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...